FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Shane Darke

Research Profile

Disorders

Geographic Areas

Activities & Behaviors

Chemicals & Drugs

Concepts & Ideas

Phenomena

Crime

Co-author Network

Publications

TOP 3
Shane Darke
Commentary on Sartor et al. (2013): Trauma and drug use-more evidence for self-medication?
Sharlene Kaye; Shane Darke; Michelle Torok
Attention deficit hyperactivity disorder (ADHD) among illicit psychostimulant users: a hidden disorder?
Shane Darke
Pathways to heroin dependence: time to re-appraise self-medication.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Shane Darke (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Shane Darke
Commentary on Sartor et al. (2013): Trauma and drug use-more evidence for self-medication?
Addiction (Abingdon, England) 2013;108(5):1001.
2013: Sharlene Kaye; Shane Darke; Michelle Torok
Attention deficit hyperactivity disorder (ADHD) among illicit psychostimulant users: a hidden disorder?
Addiction (Abingdon, England) 2013;108(5):923-31.
2013: Shane Darke
Pathways to heroin dependence: time to re-appraise self-medication.
Addiction (Abingdon, England) 2013;108(4):659-67.
2013: Skye McDonald; Shane Darke; Sharlene Kaye; Michelle Torok
Deficits in social perception in opioid maintenance patients, abstinent opioid users and non-opioid users.
Addiction (Abingdon, England) 2013;108(3):566-74.
2012: Shane Darke; Sharlene Kaye; Skye McDonald; Michelle Torok
Comparative patterns of cognitive performance amongst opioid maintenance patients, abstinent opioid users and non-opioid users.
Drug and alcohol dependence 2012;126(3):309-15.
2012: Joanne Ross; Erin Kelly; Shane Darke; Kate Hetherington
Suicide risk assessment practices: a national survey of generalist drug and alcohol residential rehabilitation services.
Drug and alcohol review 2012;31(6):790-6.
2012: Shane Darke; Sharlene Kaye; Michelle Torok
Age-related patterns of drug use initiation among polydrug using regular psychostimulant users.
Drug and alcohol review 2012;31(6):784-9.
2012: Shane Darke; Mark Deady; Johan Duflou
Toxicology and characteristics of deaths involving zolpidem in New South Wales, Australia 2001-2010.
Journal of forensic sciences 2012;57(5):1259-62.
2012: Shane Darke; Lucy Burns
Commentary on Friguls et al. (2012): illicit drugs and pregnancy--testing is not a substitute for good clinical rapport.
Addiction (Abingdon, England) 2012;107(8):1480-1.
2012: Shane Darke; Gabrielle Campbell; Garth Popple
Self-harm and attempted suicide among therapeutic community admissions.
Drug and alcohol review 2012;31(4):523-8.
2012: Michelle Torok; Shane Darke; Sharlene Kaye
Predisposed violent drug users versus drug users who commit violence: does the order of onset translate to differences in the severity of violent offending?
Drug and alcohol review 2012;31(4):558-65.
2012: Sharlene Kaye; Shane Darke
The diversion and misuse of pharmaceutical stimulants: what do we know and why should we care?
Addiction (Abingdon, England) 2012;107(3):467-77.
2011: Shane Darke
Oxycodone poisoning: not just the 'usual suspects'.
Addiction (Abingdon, England) 2011;106(6):1035-6.
2011: Shane Darke; Katherine L Mills; Joanne Ross; Maree Teesson
Rates and correlates of mortality amongst heroin users: findings from the Australian Treatment Outcome Study (ATOS), 2001-2009.
Drug and alcohol dependence 2011;115(3):190-5.
2011: Shane Darke; Johan Duflou; Michelle Torok
Toxicology and characteristics of fatal oxycodone toxicity cases in New South Wales, Australia 1999-2008.
Journal of forensic sciences 2011;56(3):690-3.
2010: Shane Darke; Michelle Torok; Sharlene Kaye; Joanne Ross
Attempted suicide, self-harm, and violent victimization among regular illicit drug users.
Suicide & life-threatening behavior 2010;40(6):587-96.
2010: Shane Darke; Michelle Torok; Sharlene Kaye; Johan Duflou
Cardiovascular disease risk factors and symptoms among regular psychostimulant users.
Drug and alcohol review 2010;29(4):371-7.
2010: Shane Darke; Johan Duflou; Michelle Torok
Comparative toxicology of intentional and accidental heroin overdose.
Journal of forensic sciences 2010;55(4):1015-8.
2010: Shane Darke; Johan Duflou; Michelle Torok
A reduction in blood morphine concentrations amongst heroin overdose fatalities associated with a sustained reduction in street heroin purity.
Forensic science international 2010;198(1-3):118-20.
2010: Shane Darke; joanne ross; Katherine Mills; Maree Teesson; Anna Williamson; Alys Havard
Benzodiazepine use among heroin users: baseline use, current use and clinical outcome.
Drug and alcohol review 2010;29(3):250-5.
2010: Shane Darke; Michelle Torok; Sharlene Kaye; joanne ross; Rebecca McKetin
Comparative rates of violent crime among regular methamphetamine and opioid users: offending and victimization.
Addiction (Abingdon, England) 2010;105(5):916-9.
2010: Shane Darke
The toxicology of homicide offenders and victims: A review.
Drug and alcohol review 2010;29(2):202-15.
2010: Shane Darke; Johan Duflou; Michelle Torok
The comparative toxicology and major organ pathology of fatal methadone and heroin toxicity cases.
Drug and alcohol dependence 2010;106(1):1-6.
2009: Sharlene Kaye; Shane Darke; Johan Duflou
Methylenedioxymethamphetamine (MDMA)-related fatalities in Australia: demographics, circumstances, toxicology and major organ pathology.
Drug and alcohol dependence 2009;104(3):254-61.
2009: Elizabeth Maloney; Louisa Degenhardt; Shane Darke; Elliot C Nelson
Are non-fatal opioid overdoses misclassified suicide attempts? Comparing the associated correlates.
Addictive behaviors 2009;34(9):723-9.
2009: Elizabeth Maloney; Louisa Degenhardt; Shane Darke; Elliot C Nelson
Impulsivity and borderline personality as risk factors for suicide attempts among opioid-dependent individuals.
Psychiatry research 2009;169(1):16-21.
2009: Shane Darke; Johan Duflou; Michelle Torok
Drugs and violent death: comparative toxicology of homicide and non-substance toxicity suicide victims.
Addiction (Abingdon, England) 2009;104(6):1000-5.
2009: Shane Darke; Katherine L Mills; joanne ross; Anna Williamson; Alys Havard; Maree Teesson
The ageing heroin user: career length, clinical profile and outcomes across 36 months.
Drug and alcohol review 2009;28(3):243-9.
2009: Shane Darke; Katherine Mills; Maree Teesson; joanne ross; Anna Williamson; Alys Havard
Patterns of major depression and drug-related problems amongst heroin users across 36 months.
Psychiatry research 2009;166(1):7-14.
2009: Shane Darke; Johan Duflou; Michelle Torok
Toxicology and circumstances of completed suicide by means other than overdose.
Journal of forensic sciences 2009;54(2):490-4.
2009: Anna Williamson; Shane Darke; joanne ross; Maree Teesson
Changes and predictors of change in the physical health status of heroin users over 24 months.
Addiction (Abingdon, England) 2009;104(3):465-70.
2009: James Shearer; Shane Darke; Craig Rodgers; Tim Slade; Ingrid van Beek; John Lewis; Donna Brady; Rebecca McKetin; Richard P Mattick; Alex Wodak
A double-blind, placebo-controlled trial of modafinil (200 mg/day) for methamphetamine dependence.
Addiction (Abingdon, England) 2009;104(2):224-33.
2008: Sharlene Kaye; Shane Darke; Johan Duflou; Rebecca McKetin
Methamphetamine-related fatalities in Australia: demographics, circumstances, toxicology and major organ pathology.
Addiction (Abingdon, England) 2008;103(8):1353-60.
2008: Shane Darke
Truth is not always found in the laboratory.
Addiction (Abingdon, England) 2008;103(7):1066-7; discussion 1067-8.
2008: Shane Darke; Sharlene Kaye; Rebecca McKetin; Johan Duflou
Major physical and psychological harms of methamphetamine use.
Drug and alcohol review 2008;27(3):253-62.
2008: Shane Darke; Johan Duflou
Toxicology and circumstances of death of homicide victims in New South Wales, Australia 1996-2005.
Journal of forensic sciences 2008;53(2):447-51.
2008: Shane Darke
From the can to the coffin: deaths among recently released prisoners.
Addiction (Abingdon, England) 2008;103(2):256-7.
2008: Maree Teesson; Katherine Mills; joanne ross; Shane Darke; Anna Williamson; Alys Havard
The impact of treatment on 3 years' outcome for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS).
Addiction (Abingdon, England) 2008;103(1):80-8.
2007: Elizabeth Maloney; Louisa Degenhardt; Shane Darke; Richard P Mattick; Elliot Nelson
Suicidal behaviour and associated risk factors among opioid-dependent individuals: a case-control study.
Addiction (Abingdon, England) 2007;102(12):1933-41.
2007: Shane Darke; Johan Duflou; Sharlene Kaye
Comparative toxicology of fatal heroin overdose cases and morphine positive homicide victims.
Addiction (Abingdon, England) 2007;102(11):1793-7.
2007: Anna Williamson; Shane Darke; joanne ross; Maree Teesson
The effect of baseline cocaine use on treatment outcomes for heroin dependence over 24 months: findings from the Australian Treatment Outcome Study.
Journal of substance abuse treatment 2007;33(3):287-93.
2007: Shane Darke; joanne ross; Katherine L Mills; Anna Williamson; Alys Havard; Maree Teesson
Patterns of sustained heroin abstinence amongst long-term, dependent heroin users: 36 months findings from the Australian Treatment Outcome Study (ATOS).
Addictive behaviors 2007;32(9):1897-906.
2007: Sharlene Kaye; Rebecca McKetin; Johan Duflou; Shane Darke
Methamphetamine and cardiovascular pathology: a review of the evidence.
Addiction (Abingdon, England) 2007;102(8):1204-11.
2007: Shane Darke; joanne ross; Anna Williamson; Katherine L Mills; Alys Havard; Maree Teesson
Borderline personality disorder and persistently elevated levels of risk in 36-month outcomes for the treatment of heroin dependence.
Addiction (Abingdon, England) 2007;102(7):1140-6.
2007: Katherine Mills; Maree Teesson; Shane Darke; joanne ross
Reliability of self-reported trauma exposure among people with heroin dependence: a longitudinal investigation.
Journal of traumatic stress 2007;20(3):313-23.
2007: Shane Darke; joanne ross; Anna Williamson; Katherine L Mills; Alys Havard; Maree Teesson
Patterns and correlates of attempted suicide by heroin users over a 3-year period: findings from the Australian treatment outcome study.
Drug and alcohol dependence 2007;87(2-3):146-52.
2007: Shane Darke; Alys Havard; joanne ross; Anna Williamson; Katherine L Mills; Maree Teesson
Changes in the use of medical services and prescription drugs among heroin users over two years.
Drug and alcohol review 2007;26(2):153-9.
2007: Katherine L Mills; Maree Teesson; joanne ross; Shane Darke
The impact of post-traumatic stress disorder on treatment outcomes for heroin dependence.
Addiction (Abingdon, England) 2007;102(3):447-54.
2007: Shane Darke; Anna Williamson; joanne ross; Katherine L Mills; Alys Havard; Maree Teesson
Patterns of nonfatal heroin overdose over a 3-year period: findings from the Australian treatment outcome study.
Journal of urban health : bulletin of the New York Academy of Medicine 2007;84(2):283-91.
2007: Shane Darke; joanne ross; Maree Teesson
The Australian Treatment Outcome Study (ATOS): what have we learnt about treatment for heroin dependence?
Drug and alcohol review 2007;26(1):49-54.
2006: Shane Darke; Sharlene Kaye; Johan Duflou
Comparative cardiac pathology among deaths due to cocaine toxicity, opioid toxicity and non-drug-related causes.
Addiction (Abingdon, England) 2006;101(12):1771-7.
2006: Shane Darke; Anna Williamson; joanne ross; Maree Teesson
Reductions in heroin use are not associated with increases in other drug use: 2-year findings from the Australian Treatment Outcome Study.
Drug and alcohol dependence 2006;84(2):201-5.
2006: Shane Darke; Sharlene Kaye; Johan Duflou
Systemic disease among cases of fatal opioid toxicity.
Addiction (Abingdon, England) 2006;101(9):1299-305.
2006: Maree Teesson; joanne ross; Shane Darke; michael lynskey; Robert Ali; Alison Ritter; Richard Cooke
One year outcomes for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS).
Drug and alcohol dependence 2006;83(2):174-80.
2006: Alys Havard; Maree Teesson; Shane Darke; joanne ross
Depression among heroin users: 12-Month outcomes from the Australian Treatment Outcome Study (ATOS).
Journal of substance abuse treatment 2006;30(4):355-62.
2006: Maree Teesson; Alys Havard; joanne ross; Shane Darke
Outcomes after detoxification for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS).
Drug and alcohol review 2006;25(3):241-7.
2006: Anna Williamson; Shane Darke; joanne ross; Maree Teesson
The association between cocaine use and short-term outcomes for the treatment of heroin dependence: findings from the Australian Treatment Outcome Study (ATOS).
Drug and alcohol review 2006;25(2):141-8.
2006: Anna Williamson; Shane Darke; joanne ross; Maree Teesson
The effect of persistence of cocaine use on 12-month outcomes for the treatment of heroin dependence.
Drug and alcohol dependence 2006;81(3):293-300.
2005: Shane Darke; Anna Williamson; joanne ross; Maree Teesson
Non-fatal heroin overdose, treatment exposure and client characteristics: findings from the Australian treatment outcome study (ATOS).
Drug and alcohol review 2005;24(5):425-32.
2005: joanne ross; Maree Teesson; Shane Darke; michael lynskey; Robert Ali; Alison Ritter; Richard Cooke
The characteristics of heroin users entering treatment: findings from the Australian treatment outcome study (ATOS).
Drug and alcohol review 2005;24(5):411-8.
2005: Katherine L Mills; Maree Teesson; joanne ross; Shane Darke; Marian Shanahan
The costs and outcomes of treatment for opioid dependence associated with posttraumatic stress disorder.
Psychiatric services (Washington, D.C.) 2005;56(8):940-5.
2005: Shane Darke; joanne ross; Anna Williamson; Maree Teesson
The impact of borderline personality disorder on 12-month outcomes for the treatment of heroin dependence.
Addiction (Abingdon, England) 2005;100(8):1121-30.
2005: Maree Teesson; Alys Havard; Sandra Fairbairn; joanne ross; michael lynskey; Shane Darke
Depression among entrants to treatment for heroin dependence in the Australian Treatment Outcome Study (ATOS): prevalence, correlates and treatment seeking.
Drug and alcohol dependence 2005;78(3):309-15.
2005: Shane Darke; Anna Williamson; joanne ross; Maree Teesson
Attempted suicide among heroin users: 12-month outcomes from the Australian Treatment Outcome Study (ATOS).
Drug and alcohol dependence 2005;78(2):177-86.
2005: Shane Darke; joanne ross; Maree Teesson; Robert Ali; Richard Cooke; Alison Ritter; michael lynskey
Factors associated with 12 months continuous heroin abstinence: findings from the Australian Treatment Outcome Study (ATOS).
Journal of substance abuse treatment 2005;28(3):255-63.
2005: Katherine L Mills; michael lynskey; Maree Teesson; joanne ross; Shane Darke
Post-traumatic stress disorder among people with heroin dependence in the Australian treatment outcome study (ATOS): prevalence and correlates.
Drug and alcohol dependence 2005;77(3):243-9.
2005: Shane Darke; joanne ross; Maree Teesson
Twelve-month outcomes for heroin dependence treatments: does route of administration matter?
Drug and alcohol review 2005;24(2):165-71.
2005: Shane Darke; Sharlene Kaye; Johan Duflou
Cocaine-related fatalities in New South Wales, Australia 1993-2002.
Drug and alcohol dependence 2005;77(2):107-14.
2004: Sharlene Kaye; Shane Darke
Injecting and non-injecting cocaine use in Sydney, Australia: physical and psychological morbidity.
Drug and alcohol review 2004;23(4):391-8.
2004: Sharlene Kaye; Shane Darke
Non-fatal cocaine overdose among injecting and non-injecting cocaine users in Sydney, Australia.
Addiction (Abingdon, England) 2004;99(10):1315-22.
2004: Erin Kelly; Shane Darke; joanne ross
A review of drug use and driving: epidemiology, impairment, risk factors and risk perceptions.
Drug and alcohol review 2004;23(3):319-44.
2004: Shane Darke; Sharlene Kaye
Attempted suicide among injecting and noninjecting cocaine users in Sydney, Australia.
Journal of urban health : bulletin of the New York Academy of Medicine 2004;81(3):505-15.
2004: Katherine L Mills; Maree Teesson; Shane Darke; joanne ross; michael lynskey
Young people with heroin dependence: findings from the Australian Treatment Outcome Study (ATOS).
Journal of substance abuse treatment 2004;27(1):67-73.
2004: Shane Darke; Kate Hetherington; joanne ross; michael lynskey; Maree Teesson
Non-injecting routes of administration among entrants to three treatment modalities for heroin dependence.
Drug and alcohol review 2004;23(2):177-83.
2004: Shane Darke; Anna Williamson; joanne ross; Maree Teesson; michael lynskey
Borderline personality disorder, antisocial personality disorder and risk-taking among heroin users: findings from the Australian Treatment Outcome Study (ATOS).
Drug and alcohol dependence 2004;74(1):77-83.
2004: Libby Topp; Courtney Breen; Sharlene Kaye; Shane Darke
Adapting the Illicit Drug Reporting System (IDRS) to examine the feasibility of monitoring trends in the markets for 'party drugs'.
Drug and alcohol dependence 2004;73(2):189-97.
2004: Shane Darke; Erin Kelly; joanne ross
Drug driving among injecting drug users in Sydney, Australia: prevalence, risk factors and risk perceptions.
Addiction (Abingdon, England) 2004;99(2):175-85.
2004: Shane Darke; joanne ross; michael lynskey; Maree Teesson
Attempted suicide among entrants to three treatment modalities for heroin dependence in the Australian Treatment Outcome Study (ATOS): prevalence and risk factors.
Drug and alcohol dependence 2004;73(1):1-10.
2003: Shane Darke; joanne ross; Maree Teesson; michael lynskey
Health service utilization and benzodiazepine use among heroin users: findings from the Australian Treatment Outcome Study (ATOS).
Addiction (Abingdon, England) 2003;98(8):1129-35.
2003: Shane Darke; Wayne Hall
Heroin overdose: research and evidence-based intervention.
Journal of urban health : bulletin of the New York Academy of Medicine 2003;80(2):189-200.
2003: Fiona Shand; Libby Topp; Shane Darke; Toni Makkai; Paul Griffiths
The monitoring of drug trends in Australia.
Drug and alcohol review 2003;22(1):61-72.
2003: Shane Darke; joanne ross; michael lynskey
The relationship of conduct disorder to attempted suicide and drug use history among methadone maintenance patients.
Drug and alcohol review 2003;22(1):21-5.
2003: Louisa Degenhardt; Shane Darke; Paul Dillon
The prevalence and correlates of gamma-hydroxybutyrate (GHB) overdose among Australian users.
Addiction (Abingdon, England) 2003;98(2):199-204.
2003: Carolyn Day; Libby Topp; David Rouen; Shane Darke; Wayne Hall; Kate Dolan
Decreased heroin availability in Sydney in early 2001.
Addiction (Abingdon, England) 2003;98(1):93-5.
2002: Libby Topp; Louisa Degenhardt; Sharlene Kaye; Shane Darke
The emergence of potent forms of methamphetamine in Sydney, Australia: a case study of the IDRS as a strategic early warning system.
Drug and alcohol review 2002;21(4):341-8.
2002: Shane Darke; joanne ross
Suicide among heroin users: rates, risk factors and methods.
Addiction (Abingdon, England) 2002;97(11):1383-94.
2002: Shane Darke; Wayne Hall; Sharlene Kaye; joanne ross; Johan Duflou
Hair morphine concentrations of fatal heroin overdose cases and living heroin users.
Addiction (Abingdon, England) 2002;97(8):977-84.
2002: Matthew Warner-Smith; Shane Darke; Carolyn Day
Morbidity associated with non-fatal heroin overdose.
Addiction (Abingdon, England) 2002;97(8):963-7.
2002: Sharlene Kaye; Shane Darke
Determining a diagnostic cut-off on the Severity of Dependence Scale (SDS) for cocaine dependence.
Addiction (Abingdon, England) 2002;97(6):727-31.
2002: Louisa Degenhardt; Shane Darke; Paul Dillon
GHB use among Australians: characteristics, use patterns and associated harm.
Drug and alcohol dependence 2002;67(1):89-94.
2002: Shane Darke; Sharlene Kaye; Libby Topp
Cocaine use in New South Wales, Australia, 1996-2000: 5 year monitoring of trends in price, purity, availability and use from the illicit drug reporting system.
Drug and alcohol dependence 2002;67(1):81-8.
2002: Shane Darke; Libby Topp; joanne ross
The injection of methadone and benzodiazepines among Sydney injecting drug users 1996-2000: 5-year monitoring of trends from the Illicit Drug Reporting System.
Drug and alcohol review 2002;21(1):27-32.
2002: Shane Darke; Ibby Topp; Harlene Kaye; Wayne Hall
Heroin use in New South Wales, Australia, 1996-2000: 5 year monitoring of trends in price, purity, availability and use from the Illicit Drug Reporting System (IDRS).
Addiction (Abingdon, England) 2002;97(2):179-86.
2001: Shane Darke; joanne ross
The relationship between suicide and heroin overdose among methadone maintenance patients in Sydney, Australia.
Addiction (Abingdon, England) 2001;96(10):1443-53.
2001: Matthew Warner-Smith; Shane Darke; michael lynskey; Wayne Hall
Heroin overdose: causes and consequences.
Addiction (Abingdon, England) 2001;96(8):1113-25.
2001: Shane Darke; joanne ross; Sharlene Kaye
Physical injecting sites among injecting drug users in Sydney, Australia.
Drug and alcohol dependence 2001;62(1):77-82.
2001: Shane Darke; Sharlene Kaye; joanne ross
Geographical injecting locations among injecting drug users in Sydney, Australia.
Addiction (Abingdon, England) 2001;96(2):241-6.
2000: joanne ross; Shane Darke
The nature of benzodiazepine dependence among heroin users in Sydney, Australia.
Addiction (Abingdon, England) 2000;95(12):1785-93.
2000: Shane Darke; joanne ross; Deborah Zador; Sandra Sunjic
Heroin-related deaths in New South Wales, Australia, 1992-1996.
Drug and alcohol dependence 2000;60(2):141-50.
2000: Shane Darke; J Sims; S McDonald; W Wickes
Cognitive impairment among methadone maintenance patients.
Addiction (Abingdon, England) 2000;95(5):687-95.
2000: Shane Darke; joanne ross
Fatal heroin overdoses resulting from non-injecting routes of administration, NSW, Australia, 1992-1996.
Addiction (Abingdon, England) 2000;95(4):569-73.
2000: Shane Darke; joanne ross
The use of antidepressants among injecting drug users in Sydney, Australia.
Addiction (Abingdon, England) 2000;95(3):407-17.
2000: Sharlene Kaye; Shane Darke
A comparison of the harms associated with the injection of heroin and amphetamines.
Drug and alcohol dependence 2000;58(1-2):189-95.
1999: Shane Darke; Sharlene Kaye; joanne ross
Transitions between the injection of heroin and amphetamines.
Addiction (Abingdon, England) 1999;94(12):1795-803.
1999: Shane Darke; Wayne Hall; Don Weatherburn; Bronwyn Lind
Fluctuations in heroin purity and the incidence of fatal heroin overdose.
Drug and alcohol dependence 1999;54(2):155-61.
1999: Shane Darke
Attacking overdose on the home front.
Addiction (Abingdon, England) 1999;94(2):205-6; discussion 207.
1998: Sharlene Kaye; Shane Darke; R Finlay-Jones
The onset of heroin use and criminal behaviour: does order make a difference?
Drug and alcohol dependence 1998;53(1):79-86.
1998: Wayne Hall; Shane Darke
Trends in opiate overdose deaths in Australia 1979-1995.
Drug and alcohol dependence 1998;52(1):71-7.
1998: Shane Darke; Sharlene Kaye; R Finlay-Jones
Antisocial personality disorder, psychopathy and injecting heroin use.
Drug and alcohol dependence 1998;52(1):63-9.
1998: Shane Darke; Sharlene Kaye; R Finlay-Jones
Drug use and injection risk-taking among prison methadone maintenance patients.
Addiction (Abingdon, England) 1998;93(8):1169-75.
1998: Shane Darke
Self-report among injecting drug users: a review.
Drug and alcohol dependence 1998;51(3):253-63; discussion 267-8.
1998: Shane Darke; Sharlene Kaye; R Finlay-Jones; Wayne Hall
Factor structure of psychopathy among methadone maintenance patients.
Journal of personality disorders 1998;12(2):162-71.
1997: Shane Darke; joanne ross
Polydrug dependence and psychiatric comorbidity among heroin injectors.
Drug and alcohol dependence 1997;48(2):135-41.
1997: Libby Topp; Shane Darke
The applicability of the dependence syndrome to amphetamine.
Drug and alcohol dependence 1997;48(2):113-8.
1997: Shane Darke; Wayne Hall
The distribution of naloxone to heroin users.
Addiction (Abingdon, England) 1997;92(9):1195-9.
1997: Shane Darke; Sandra Sunjic; Deborah Zador; T Prolov
A comparison of blood toxicology of heroin-related deaths and current heroin users in Sydney, Australia.
Drug and alcohol dependence 1997;47(1):45-53.
1997: joanne ross; Shane Darke; Wayne Hall
Transitions between routes of benzodiazepine administration among heroin users in Sydney.
Addiction (Abingdon, England) 1997;92(6):697-705.
1996: Shane Darke; joanne ross; Wayne Hall
Prevalence and correlates of the injection of methadone syrup in Sydney, Australia.
Drug and alcohol dependence 1996;43(3):191-8.
1996: Shane Darke; Deborah Zador
Fatal heroin 'overdose': a review.
Addiction (Abingdon, England) 1996;91(12):1765-72.
1996: J Ward; Richard P Mattick; Wayne Hall; Shane Darke
The effectiveness and safety of methadone maintenance.
Addiction (Abingdon, England) 1996;91(11):1727-9.
1996: Shane Darke; R Finlay-Jones; Sharlene Kaye; T Blatt
Anti-social personality disorder and response to methadone maintenance treatment.
Drug and alcohol review 1996;15(3):271-6.
1996: J Ross; Shane Darke; Wayne Hall
Benzodiazepine use among heroin users in Sydney: patterns of use, availability and procurement.
Drug and alcohol review 1996;15(3):237-43.
1996: M Kelaher; Shane Darke; Wayne Hall; B Flaherty
Characteristics of admissions to residential drug treatment agencies in New South Wales, 1988-92: II. Alcohol problems.
Drug and alcohol review 1996;15(2):133-6.
1996: Shane Darke; M Kelaher; Wayne Hall; B Flaherty
Characteristics of admissions to residential drug treatment agencies in New South Wales, 1988-92: I. Illicit drug problems.
Drug and alcohol review 1996;15(2):127-32.
1996: Shane Darke; joanne ross; Wayne Hall
Overdose among heroin users in Sydney, Australia: II. responses to overdose.
Addiction (Abingdon, England) 1996;91(3):413-7.
1996: Shane Darke; joanne ross; Wayne Hall
Overdose among heroin users in Sydney, Australia: I. Prevalence and correlates of non-fatal overdose.
Addiction (Abingdon, England) 1996;91(3):405-11.
1996: Deborah Zador; Sandra Sunjic; Shane Darke
Heroin-related deaths in New South Wales, 1992: toxicological findings and circumstances.
The Medical journal of Australia 1996;164(4):204-7.
1996: Wayne Hall; J Hando; Shane Darke; joanne ross
Psychological morbidity and route of administration among amphetamine users in Sydney, Australia.
Addiction (Abingdon, England) 1996;91(1):81-7.
1995: Shane Darke; Wayne Hall
Levels and correlates of polydrug use among heroin users and regular amphetamine users.
Drug and alcohol dependence 1995;39(3):231-5.
1995: Shane Darke; J E Ross; W D Hall
Benzodiazepine use among injecting heroin users.
The Medical journal of Australia 1995;162(12):645-7.
1995: Michael Gossop; Shane Darke; P Griffiths; J Hando; B Powis; Wayne Hall; J Strang
The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users.
Addiction (Abingdon, England) 1995;90(5):607-14.
1995: Richard P Mattick; Shane Darke
Drug replacement treatments: is amphetamine substitution a horse of a different colour?
Drug and alcohol review 1995;14(4):389-94.
1995: Shane Darke; joanne ross; J Cohen; J Hando; Wayne Hall
Injecting and sexual risk-taking behaviour among regular amphetamine users.
AIDS care 1995;7(1):19-26.
1994: Shane Darke; joanne ross; J Cohen
The use of benzodiazepines among regular amphetamine users.
Addiction (Abingdon, England) 1994;89(12):1683-90.
1994: Shane Darke; J Cohen; joanne ross; J Hando; Wayne Hall
Transitions between routes of administration of regular amphetamine users.
Addiction (Abingdon, England) 1994;89(9):1077-83.
1994: Shane Darke; Wendy Swift; Wayne Hall; M Ross
Predictors of injecting and injecting risk-taking behaviour among methadone-maintenance clients.
Addiction (Abingdon, England) 1994;89(3):311-6.
1994: Shane Darke; Wendy Swift; Wayne Hall
Prevalence, severity and correlates of psychological morbidity among methadone maintenance clients.
Addiction (Abingdon, England) 1994;89(2):211-7.
1994: Shane Darke; Wayne Hall; Wendy Swift
Prevalence, symptoms and correlates of antisocial personality disorder among methadone maintenance clients.
Drug and alcohol dependence 1994;34(3):253-7.
1993: Wayne Hall; Shane Darke; M Ross; Alex Wodak
Patterns of drug use and risk-taking among injecting amphetamine and opioid drug users in Sydney, Australia.
Addiction (Abingdon, England) 1993;88(4):509-16.
1992: Shane Darke; Wayne Hall; M Ross; Alex Wodak
Benzodiazepine use and HIV risk-taking behaviour among injecting drug users.
Drug and alcohol dependence 1992;31(1):31-6.
1992: Shane Darke; Alex Wodak; Wayne Hall; N Heather; J Ward
Prevalence and predictors of psychopathology among opioid users.
British journal of addiction 1992;87(5):771-6.
1992: Shane Darke; Wayne Hall; Alex Wodak; N Heather; J Ward
Development and validation of a multi-dimensional instrument for assessing outcome of treatment among opiate users: the Opiate Treatment Index.
British journal of addiction 1992;87(5):733-42.
1992: M W Ross; Shane Darke
Mad, bad and dangerous to know: dimensions and measurement of attitudes toward injecting drug users.
Drug and alcohol dependence 1992;30(1):71-4.
1992: J Ward; Shane Darke; Wayne Hall; Richard P Mattick
Methadone maintenance and the human immunodeficiency virus: current issues in treatment and research.
British journal of addiction 1992;87(3):447-53.
1992: Shane Darke; A Baker; J Dixon; Alex Wodak; N Heather
Drug use and HIV risk-taking behaviour among clients in methadone maintenance treatment.
Drug and alcohol dependence 1992;29(3):263-8.
1991: Shane Darke; J Ward; Deborah Zador; G Swift
A scale for estimating the health status of opioid users.
British journal of addiction 1991;86(10):1317-22.
1991: Shane Darke; N Heather; Wayne Hall; J Ward; Alex Wodak
Estimating drug consumption in opioid users: reliability and validity of a 'recent use' episodes method.
British journal of addiction 1991;86(10):1311-6.
1990: Shane Darke; Wayne Hall; J Carless
Drug use, injecting practices and sexual behaviour of opioid users in Sydney, Australia.
British journal of addiction 1990;85(12):1603-9.
1990: Shane Darke; Wayne Hall; J Carless
The injecting and sexual behaviour of intravenous drug users in Sydney.
The Medical journal of Australia 1990;152(8):446.